(Q44044525)

29 November 2017

Estrogen receptor-mediated effects of tamoxifen on human endometrial cancer cells (English)

1 reference

29 November 2017

1 reference

1 reference

Takako Sakamoto

1

1 reference

29 November 2017

Hidetaka Eguchi

2

1 reference

29 November 2017

Yoko Omoto

3

1 reference

29 November 2017

Takuya Ayabe

4

1 reference

29 November 2017

Hiroyuki Mori

5

1 reference

29 November 2017

Shin-ichi Hayashi

6

1 reference

29 November 2017

1 June 2002

1 reference

Molecular and Cellular Endocrinology

29 November 2017

1 reference

29 November 2017

192

1 reference

29 November 2017

93-104

1 reference

29 November 2017

1-2

1 reference

Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Estrogen response elements can mediate agonist activity of anti-estrogens in human endometrial Ishikawa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

A transcriptional co-repressor that interacts with nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Nuclear receptor conformation, coregulators, and tamoxifen-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Effects of estradiol on proliferation of endometrial adenocarcinoma cells (Ishikawa line).

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Establishment of human endometrial adenocarcinoma cell line containing estradiol-17 beta and progesterone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

The effect of anti-oestrogens on cell growth and progesterone receptor concentration in human endometrial cancer cells (Ishikawa).

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Molecular mechanism of a cross-talk between oestrogen and growth factor signalling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

p300 Mediates Functional Synergism between AF-1 and AF-2 of Estrogen Receptor α and β by Interacting Directly with the N-terminal A/B Domains

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Establishment of a cell line of human endometrial adenocarcinoma in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Estrogens cause rapid activation of IP3-PKC-alpha signal transduction pathway in HEPG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

The nuclear receptor ligand-binding domain: structure and function.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture models

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

KLE: a cell line with defective estrogen receptor derived from undifferentiated endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Estrogen receptor cofactors expression in breast and endometrial human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

Estrogen receptor activation function 1 works by binding p160 coactivator proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900086-2

7 January 2021

10.1016/S0303-7207(02)00086-2

Identifiers

DOI

1 reference

29 November 2017

1 reference